TY  - GEN
AU  - Suter,Thomas M
AU  - Procter,Marion
AU  - van Veldhuisen,Dirk J
AU  - Muscholl,Michael
AU  - Bergh,Jonas
AU  - Carlomagno,Chiara
AU  - Perren,Timothy
AU  - Passalacqua,Rodolfo
AU  - Bighin,Claudia
AU  - Klijn,Jan G M
AU  - Ageev,Fail T
AU  - Hitre,Erika
AU  - Groetz,Juergen
AU  - Iwata,Hiroji
AU  - Knap,Malgorzata
AU  - Gnant,Michael
AU  - Muehlbauer,Susanne
AU  - Spence,Alison
AU  - Gelber,Richard D
AU  - Piccart-Gebhart,Martine J
TI  - Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
SN  - 1527-7755
PY  - 2007///0911
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cardiovascular Diseases
KW  - chemically induced
KW  - Disease-Free Survival
KW  - Female
KW  - Heart Failure
KW  - Humans
KW  - Middle Aged
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Trastuzumab
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2006.09.1611
ER  -